← Open Payments lookup

KELLIE KOZAK: Open Payments

NPI 1255716825 · VOORHEES, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$730 in 50 payments from 10 companies in 2025. Trend: 2023 $504 · 2024 $189 · 2025 $730

Food & beverage: $674Education: $56
CompanyPaymentsAmount
GENZYME CORPORATION11$233
GlaxoSmithKline, LLC.21$150
ARS Pharmaceuticals Operations, Inc.5$92
Genentech USA, Inc.4$65
SANOFI-AVENTIS U.S. LLC1$56
Amgen Inc.3$47
Optinose US, Inc.2$28
ALK-Abello, Inc1$27
AstraZeneca Pharmaceuticals LP1$18
Hikma Pharmaceuticals USA1$16

Products named: DUPIXENT, NUCALA, NEFFY, Xolair, TEZSPIRE, Xhance, Grastek, Ryaltris.

Industry payments across NJ — which companies pay providers there.